Journal list menu
IssueCancer Communications: Volume 43, Issue 9
i, 961-1068September 2023
Export Citations
Download PDFs
FEATURED COVER
Cover Image, Volume 43, Issue 9
- Page: i
- First Published: 19 September 2023
The cover image is based on the Correspondence Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcinoma: a proof-of-concept treatment strategy by Yaoping Shi et al., https://doi.org/10.1002/cac2.12472.
ISSUE INFORMATION
ORIGINAL ARTICLES
Worldwide trends in esophageal cancer survival, by sub-site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000-2014 (CONCORD-3)
- Pages: 963-980
- First Published: 24 July 2023
HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression
- Pages: 981-1002
- First Published: 05 July 2023
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors
- Pages: 1003-1026
- First Published: 11 July 2023
Bifidobacterium adolescentis orchestrates CD143+ cancer-associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling-regulated GAS1
- Pages: 1027-1047
- First Published: 02 August 2023
RESEARCH HIGHLIGHT
Uncovering the IL-1β-PCAF-NNT axis: A new player in ferroptosis and tumor immune evasion
- Pages: 1048-1050
- First Published: 24 July 2023
LETTERS TO THE EDITOR
Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft-tissue sarcomas
- Pages: 1051-1054
- First Published: 05 July 2023
Single-cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions
- Pages: 1055-1058
- First Published: 04 June 2023
A phase II study on Mefatinib as first-line treatment of patients with advanced non-small-cell lung cancer harboring uncommon EGFR mutations
- Pages: 1059-1063
- First Published: 15 June 2023
Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcinoma: a proof-of-concept treatment strategy
- Pages: 1064-1068
- First Published: 21 July 2023
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)